These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4665286)

  • 1. Effects of pyridoxal phosphate and L-dopapyridoxal phosphate on DOPA decarboxylase activity.
    Tran N
    Experientia; 1972 Sep; 28(9):1021-2. PubMed ID: 4665286
    [No Abstract]   [Full Text] [Related]  

  • 2. The enzymatic decarboxylation of DOPA in human liver homogenates.
    Vogel WH; Snyder R; Hare TA
    Proc Soc Exp Biol Med; 1970 Jun; 134(2):477-81. PubMed ID: 5310151
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorpromazine-induced accumulation of pyridoxal-5'-phosphate and activation of the decarboxylase of aromatic amino acids in rat brain.
    Gey KF; Burkard WP
    Ann N Y Acad Sci; 1969 Sep; 166(1):213-24. PubMed ID: 5308031
    [No Abstract]   [Full Text] [Related]  

  • 4. Coenzyme--substrate adducts as inhibitors of mouse liver 3,4-dihydroxyphenylalanine decarboxylase.
    Rudd EA; Cunningham WC; Thanassi JW
    J Med Chem; 1979 Mar; 22(3):233-7. PubMed ID: 423204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved ionization chamber method for continuous measurement of DOPA decarboxylase activity.
    Tran N
    Anal Biochem; 1972 Jul; 48(1):112-9. PubMed ID: 5041398
    [No Abstract]   [Full Text] [Related]  

  • 6. Decrease in liver aromatic L-amino-acid decarboxylase produced by chronic administration of L-dopa.
    Dairman W; Christenson JG; Udenfriend S
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2117-20. PubMed ID: 5289371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decarboxylation of 3,4-dihydroxyphenylalanine by oxyhemoglobin.
    Yamabe H; Lovenberg W
    Biochem Biophys Res Commun; 1972 May; 47(4):733-9. PubMed ID: 5063594
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylase.
    Inagaki C; Tanaka C
    Biochem Pharmacol; 1978 Apr; 27(7):1081-6. PubMed ID: 26357
    [No Abstract]   [Full Text] [Related]  

  • 9. Limited tryptic proteolysis of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Simmaco M; Schininà ME; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1988 Feb; 260(2):569-76. PubMed ID: 3124758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of human red blood cell 1-3,4-dihydroxyphenylalanine decarboxylating activity.
    Dairman W; Christenson JG
    Eur J Pharmacol; 1973 May; 22(2):135-40. PubMed ID: 4736669
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of analogs of phenylalanine and tryptophan on kinetics of DOPA decarboxylase in rat brain.
    De Ropp RS; Furst A
    Brain Res; 1966 Oct; 2(4):323-32. PubMed ID: 5298124
    [No Abstract]   [Full Text] [Related]  

  • 12. How does L-dopa work in parkinsonism?
    Sandler M
    Lancet; 1971 Apr; 1(7703):784. PubMed ID: 4101278
    [No Abstract]   [Full Text] [Related]  

  • 13. 3,4-Dihydroxyphenylalanine (dopa) decarboxylase activity in the arthropod nervous system.
    Murdock LL; Wirtz RA; Köhler G
    Biochem J; 1973 Apr; 132(4):681-8. PubMed ID: 4721604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in aromatic amino acid decarboxylase activity towards DOPA and 5-hydroxytryptophan caused by pH changes and denaturation.
    Bender DA; Coulson WF
    J Neurochem; 1972 Dec; 19(12):2801-10. PubMed ID: 4652630
    [No Abstract]   [Full Text] [Related]  

  • 15. Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.
    Ribéreau-Gayon G; Palfreyman MG; Zraïka M; Wagner J; Jung MJ
    Biochem Pharmacol; 1980 Sep; 29(18):2465-9. PubMed ID: 7426053
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of L-DOPA perfusion concentrations and peripheral decarboxylase inhibition on dopa accumulation and decarboxylation in isolated perfused rat brains.
    Horst WD; Bautz G; Renyi E; Spirt N
    Neuropharmacology; 1973 Dec; 12(12):1145-51. PubMed ID: 4782694
    [No Abstract]   [Full Text] [Related]  

  • 17. Histidine decarboxylase and DOPA decarboxylase in the stomach of the developing rat.
    Aures D; Håkanson R
    Experientia; 1968 Jul; 24(7):666-7. PubMed ID: 5705217
    [No Abstract]   [Full Text] [Related]  

  • 18. Automated radiometric assays of enzymatic and nonenzymatic oxidation of DOPA in vitro.
    Tran N
    J Lab Clin Med; 1974 Aug; 84(2):287-91. PubMed ID: 4843233
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and characterization of rat-liver 3,4-dihydroxyphenylalanine decarboxylase.
    Dominici P; Tancini B; Barra D; Voltattorni CB
    Eur J Biochem; 1987 Nov; 169(1):209-13. PubMed ID: 3119338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the pharmacological action of 3,4-dihydroxy-L-phenylalanine(L-dopa) and reduction of dopa decarboxylase activity in rat liver after chronic treatment with L-dopa.
    Tanaka M; Oshima T; Hayashi S; Ishibashi C; Kobayashi S
    Eur J Pharmacol; 1973 Jun; 22(3):360-2. PubMed ID: 4732567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.